Display options
Cite
Atta MA, Kotb AF, Sharafeldeen M, et al. The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer. Arab J Urol. 2016;15(1):60-63doi: 10.1016/j.aju.2016.10.003.
Atta, M. A., Kotb, A. F., Sharafeldeen, M., Elabbady, A., & Hashad, M. M. (2017). The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer. Arab journal of urology, 15(1), 60-63. https://doi.org/10.1016/j.aju.2016.10.003
Atta, Mohamed Adel, et al. "The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer." Arab journal of urology vol. 15,1 (2017): 60-63. doi: https://doi.org/10.1016/j.aju.2016.10.003
Atta MA, Kotb AF, Sharafeldeen M, Elabbady A, Hashad MM. The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer. Arab J Urol. 2016 Nov 26;15(1):60-63. doi: 10.1016/j.aju.2016.10.003. eCollection 2017 Mar. PMID: 28275520; PMCID: PMC5329698.
Copy Download .nbib Format: NLM
Share it on

Arab J Urol. 2016 Nov 26;15(1):60-63. doi: 10.1016/j.aju.2016.10.003. eCollection 2017 Mar.

The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer.

Arab journal of urology

Mohamed Adel Atta, Ahmed Fouad Kotb, Mohamed Sharafeldeen, Ahmed Elabbady, Mohamed Mohie Hashad

Affiliations

  1. Department of Urology, Alexandria University, Alexandria, Egypt.

PMID: 28275520 PMCID: PMC5329698 DOI: 10.1016/j.aju.2016.10.003

Abstract

OBJECTIVE: To report our experience for the initial management of patients with newly diagnosed bladder tumours using our team approach for each case and using an aggressive extended transurethral resection of bladder tumour (TURBT) in order to investigate the real need for a routine 'second-look' cystoscopy in the current era.

PATIENTS AND METHODS: The study included 50 consecutive patients admitted to the urology department, of our tertiary care centre, for management of newly diagnosed bladder cancer. Exclusion criteria included past history of bladder tumour, palpable mass on bimanual examination under anaesthesia, presence of residual tumour at the end of resection, and patients with tumours of the bladder dome as thorough resection is difficult to achieve in this area without an attendant risk. Patients that had pathologically confirmed carcinoma

RESULTS: The median (range) age of the patients was 52 (39-60) years. After initial TURBT, 10 patients (20%) were identified as having muscle-invasive bladder cancer. Of the remaining 40 patients, three had low-grade Ta disease, and so second biopsies were not taken. The remaining 37 patients had T1, grade 2-3 disease and none of them had evident residual disease at the site of tumour resection.

CONCLUSION: Re-staging TURBT could be safely omitted for select groups of patients. An experienced surgeon and teamwork, together with an extended TURBT can accurately achieve complete tumour resection, with accurate tumour staging, on initial resection.

Keywords: Bladder cancer; CIS, carcinoma in situ; MIBC, muscle-invasive bladder cancer; NMIBC, non-muscle-invasive bladder cancer; RC, radical cystectomy; T1G3; TURBT; TURBT, transurethral resection of bladder tumour

References

  1. Urol Clin North Am. 1992 Aug;19(3):429-33 - PubMed
  2. J Urol. 2009 Oct;182(4):1318-24 - PubMed
  3. J Urol. 2004 Feb;171(2 Pt 1):636-9 - PubMed
  4. J Urol. 2001 Mar;165(3):808-10 - PubMed
  5. Eur Urol. 2013 Oct;64(4):639-53 - PubMed
  6. Eur Urol. 2002 May;41(5):523-31 - PubMed
  7. Minerva Urol Nefrol. 2016 Apr;68(2):204-8 - PubMed
  8. BJU Int. 2012 Jun;109(11):1666-73 - PubMed
  9. BJU Int. 2008 Nov;102(9 Pt B):1242-6 - PubMed
  10. J Urol. 1999 Jul;162(1):74-6 - PubMed
  11. Eur Urol. 2000;37 Suppl 3:1-9 - PubMed
  12. Eur Urol. 2006 Dec;50(6):1176-82 - PubMed
  13. J Urol. 2002 Jun;167(6):2404-7 - PubMed

Publication Types